49 Wealth Management’s Aura Biosciences AURA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$111K Sell
17,607
-2,957
-14% -$21.1K 0.01% 226
2026
Q2
$146K Sell
20,564
-1,140
-5% -$8.16K 0.01% 226
2026
Q1
$145K Buy
21,704
+2,720
+14% +$15.6K 0.01% 193
2025
Q4
$103K Buy
18,984
+8,375
+79% +$49.7K 0.01% 191
2025
Q3
$65.6K Buy
+10,609
New +$69.4K 0.01% 193

Other funds holding AURA

49 Wealth Management's AURA Position: Q3 2026 in Review

49 Wealth Management reduced its Aura Biosciences (AURA) stake by 14% in Q3 2026, selling an estimated $21.1K and leaving 17,607 shares worth $111K. The position accounts for 0.01% of the portfolio, ranked #226.

49 Wealth Management first reported a position in AURA in Q3 2025 and has held it in 5 quarters since. The position peaked at $146K in Q2 2026. 154 funds tracked by Wall St. Rank hold AURA as of Q3 2026.

  • 49 Wealth Management held 17,607 shares of Aura Biosciences worth $111K as of Q3 2026.
  • 49 Wealth Management sold 2,957 Aura Biosciences shares in Q3 2026, an estimated $21.1K.
  • Aura Biosciences made up 0.01% of 49 Wealth Management's portfolio in Q3 2026, its #226 holding.
  • 49 Wealth Management first reported a position in Aura Biosciences in Q3 2025 and has held it in 5 quarters since.
  • 49 Wealth Management's Aura Biosciences position peaked at $146K in Q2 2026.
  • 154 funds tracked by Wall St. Rank held Aura Biosciences as of Q3 2026.

Based on 49 Wealth Management's 13F filing for Q3 2026, filed 13 Nov 2026.